Perrigo Announces FDA Final Approval For AB Rated Generic Version Of Voltaren(R) Gel 1%

DUBLIN, May 21, 2019 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced its partner received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application (ANDA... Biopharmaceuticals, Generics, FDA, Product Launch Perrigo, Voltaren, Voltaren Gel, diclofenac
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news